Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!
What Is the Estimated Market Size of the Gut Microbiota Market In 2029?
The market size of gut microbiota has seen a fast-paced expansion in the last few years. It is projected to escalate from $0.55 billion in 2024 to about $0.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 18.5%. The surge during the historic period can be credited to the identification of probiotics and prebiotics, an increase in gastrointestinal ailments, rising interest in functional foods, the augmented usage of antibiotics, and the growth in understanding of the connection between the gut and brain.
In the coming years, a rapid expansion is anticipated in the gut microbiota market, which is forecasted to reach $1.27 billion in 2029, escalating at a compound annual growth rate (CAGR) of 18.2%. Factors contributing to this growth in the projection period comprise the growth of personalized nutrition, increased need for microbiome-based therapeutics, the surge in functional and fermented foods, and supportive regulations for probiotics and prebiotics. Primary trends for the forecast period involve AI-operated microbiome analysis, advancements in next-generation sequencing, CRISPR-focused gut microbiota editing, invention of smart probiotic delivery systems, and the advent of wearable devices for monitoring gut health.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gut Microbiota Market?
The escalating need for bespoke medical treatments is anticipated to boost the gut microbiota market’s expansion in the future. Personalized medicine consists of adapting treatment plans for each patient depending on their genetic, environmental, and lifestyle factors, improving results and enhancing care. The need for personalized medicine is surging as enhancements in genomics and biotechnology pave the way for more accurate genetic profiles, resulting in customized treatments that escalate efficacy and mitigate side effects. Personalized medicine is beneficial for gut microbiota by adapting treatments to match an individual’s distinctive microbiome composition, which enhances gut health and betters digestive and metabolic disorder outcomes. For instance, in February 2024, the US Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, as per the Personalized Medicine Coalition (PMC), an American nonprofit organization, marking a notable increase compared to the 12 approved in 2022. Consequently, the escalating need for personalized medicine is propelling the gut microbiota market’s growth.
Which Key Market Segments Comprise the Gut Microbiota Market and Drive Its Revenue Growth?
The gut microbiota market covered in this report is segmented –
1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products
2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health
3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Super markets And Hyper markets, Specialty Stores
4) By End-Users: Adults, Children, Elderly
Subsegments:
1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins
2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia
3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives
4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts
5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp
Which Areas Are Leading Regions in the Gut Microbiota Market Expansion Across the Globe?
North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing the Gut Microbiota Industry Evolution?
Leading organizations in the gut microbiota market are concentrating their efforts on creating cutting-edge solutions, such as fecal microbiota administered orally, to tackle various gastrointestinal diseases and disorders. Fecal microbiota administered orally is a treatment where a capsule or pill containing beneficial bacteria from the stool of a healthy donor is consumed to restore equilibrium to the gut microbiome. For example, Seres Therapeutics Inc., a microbiome therapeutics platform company from the US, in April 2023, secured FDA approval for Vowst, the first-ever oral fecal microbiota product fashioned to prevent repeated C. difficile infection (CDI) in individuals who are 18 years old and above. Vowst is meant to be used after antibacterial treatment for recurrent CDI. The approval of Vowst represents a considerable progression in treating CDI, offering a more accessible and patient-friendly substitute for traditional fecal microbiota transplants, which are usually given via colonoscopy or enema. The oral formulation of Vowst may boost treatment compliance and broaden the acceptance of microbiome-based therapies in healthcare.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report
How Is the Gut Microbiota Market Conceptually Defined?
Gut microbiota refers to the complex community of microorganisms, including bacteria, viruses, fungi, and other microbes, that reside in the gastrointestinal tract. These microbes play a vital role in digestion, immune function, and overall health by influencing metabolism and protecting against harmful pathogens.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23411
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model